One of the problems with clinical trials for late-stage prostate cancer today is that we commonly need to follow all patients until death before we can collect sufficiently accurate data to be certain that a particular product is or is not effective in extending patient survival. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: bone, BSI, endpoint, index, marker, scan, surrogate, survival | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 